Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, C. B.
Right arrow Articles by Thomsen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, C. B.
Right arrow Articles by Thomsen, K.
J Am Soc Nephrol 14:3102-3110, 2003
© 2003 American Society of Nephrology

BASIC SCIENCE

Decreases in Renal Functional Reserve and Proximal Tubular Fluid Output in Conscious Oophorectomized Rats: Normalization with Sex Hormone Substitution

Camilla Birch Nielsen*,{dagger}, Allan Flyvbjerg{dagger}, Jens Meldgaard Bruun{ddagger}, Axel Forman§, Lise Wogensen|| and Klaus Thomsen*

*Department of Biological Psychiatry, Institute for Basic Psychiatric Research, {dagger}Medical Research Laboratories, Institute of Experimental Clinical Research, {ddagger}Department of Endocrinology and Metabolism, §Department of Gynecology, and ||Research Laboratory for Biochemical Pathology, Institute of Experimental Clinical Research, Aarhus University Hospital, Aarhus, Denmark.

Correspondence to Dr. Klaus Thomsen, Department of Biological Psychiatry, Institute for Basic Psychiatric Research, Skovagervej 2, DK-8240 Risskov, Denmark. Phone: +45-7789-3512; Fax: +45-7789-3549; E-mail: klt{at}psykiatri.aaa.dk


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ABSTRACT. Age-dependent glomerulosclerosis with reduced GFR develops earlier among men than among women. Therefore, whether female sex hormones could prevent the age-dependent decrease in GFR was investigated. The kidney function in oophorectomized rats treated with placebo (OOX group), estrogen (OOX+E2 group), or estrogen plus progesterone (OOX+E2+P group) for 5 mo and in sham-operated rats (sham group) was examined. The rats were 13 mo of age at the time of the investigation. They were conscious and chronically instrumented. The results demonstrated that estrogen, alone or in combination with progesterone, was without effect on the baseline GFR and effective renal plasma flow but prevented severe decreases in the renal functional reserve and fractional proximal tubular fluid output (lithium clearance technique, fractional lithium excretion), which were observed in the OOX group. The renal functional reserve (estimated by stimulation with glycine) was -223 ± 151, 483 ± 129, 675 ± 76, and 208 ± 140 µl/min in the OOX, OOX+E2, OOX+E2+P, and sham groups, respectively. Fractional lithium excretion was 12.4 ± 3.1, 26.8 ± 2.0, 31.8 ± 2.5, and 23.6 ± 3.3% in the OOX, OOX+E2, OOX+E2+P, and sham groups, respectively. In conclusion, oophorectomy at the age of 8 mo did not produce a decrease in baseline GFR in female rats within a period of 5 mo. However, oophorectomy led to severe decreases in the renal functional reserve and fractional proximal tubular fluid output. Both effects were prevented with administration of estrogen. Sham-operated rats demonstrated values for renal functional reserve and fractional lithium excretion that were between those observed for the OOX group and the groups treated with sex hormones.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Gender differences in the progression of kidney failure represent a well known phenomenon. Male patients exhibit faster development of age-dependent glomerulosclerosis than do female patients (1–3). Furthermore, male patients exhibit a more rapid decline in renal function attributable to nephrotic syndrome (4), polycystic kidney disease, or chronic glomerulonephritis (5). Finally, the incidence of subnormal GFR in IgA nephropathy is higher among male patients (6).

The rapid progression of kidney failure among male subjects is also evident in animal models. Unilateral nephrectomy and contralateral ligation of two-thirds of the renal circulation produce more rapid increases in proteinuria, segmental glomerulosclerosis, and collagen {alpha}1 IV mRNA in male rats than in female rats (7). In line with this, estrogen protects male rats against the development of glomerulosclerosis (8). In mesangial cell cultures, estrogen inhibits proliferation, suppresses synthesis of collagen type I and IV, and inhibits the oxidation and uptake of LDL by macrophages (9,10). Other in vitro studies demonstrated that estrogen inhibits procollagen type III and increases the production of collagenase (11–13). Furthermore, castration of male rats seems to have a beneficial effect on the development of glomerulosclerosis (14), whereas treatment with testosterone accelerates the disease (15). Recent studies demonstrated that glomerulosclerosis susceptibility is associated with diminished estrogen receptor expression in mesangial cells (16). Taken together, these findings indicate the involvement of both hormones in age-dependent changes in renal function, through direct effects on the kidney, and they suggest that estrogen may protect against these changes. To date, no studies have been performed to explore the effects of menopause on normal kidney function.

The aim of this study was to examine whether estrogen protects premenopausal rats from age-dependent changes in renal function and whether the protection disappears when estrogen is withdrawn, through either menopause or oophorectomy. Wistar rats develop age-dependent glomerulosclerosis at 13 mo of age and demonstrate gender differences comparable to those observed for human subjects (17). To study whether estrogen could prevent age-dependent changes in renal function, we performed a detailed study involving determinations of effective renal plasma flow (ERPF), GFR, and lithium clearance in 13-mo-old conscious rats that had been oophorectomized at the age of 8 mo. One subgroup was supplemented with estrogen and another was given a combination of estrogen and progesterone. The results indicated that proximal tubular fluid output (lithium clearance) in rats supplemented with both sex hormones was more than twice the level in oophorectomized rats. Furthermore, the renal functional reserve was abolished in oophorectomized rats but was preserved in rats supplemented with ovarian sex hormones.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals and Physical Environment
Specific pathogen-free, adult, female, Wistar rats (M & B, Ry, Denmark) weighing between 240 and 300 g were used. The studies were performed in accordance with the European Community guidelines and were approved by the Danish Animal Experiments Inspectorate. Animals were housed two per cage in a room with a 12/12-h artificial light cycle (lights on from 8 a.m. to 8 p.m.), a temperature of 21 ± 2°C, and a humidity level of 55 ± 2%. The rats were fed a special synthetic estrogen-free diet (C-1000; Altromin GmbH, Lage, Germany) from the age of 8 mo and throughout the experimental period (until the rats were 13 mo of age). The diet contained 17.3% protein, 110 mmol/kg sodium, and 180 mmol/kg potassium. Three days before clearance measurements, this diet was changed to one containing lithium chloride (12 mmol/kg dry weight), to yield measurable plasma lithium concentrations without affecting renal function (18). Rats had free access to food and tap water throughout the studies.

Surgical Preparation
Eight-month-old rats were randomized into four groups, as follows: (1) oophorectomized and substituted with placebo (placebo pellet, 90-d release) (OOX group), (2) oophorectomized and substituted with 17{beta}-estradiol (0.85 mg/pellet, 90-d release) (OOX+E2 group), (3) oophorectomized and substituted with 17{beta}-estradiol and progesterone (0.85 mg/pellet and 200 mg/pellet, respectively, 90-d release) (OOX+E2+P group), and (4) sham-operated (sham group). The pellets (Innovative Research of America, Sarasota, FL) were implanted subcutaneously between the scapulae, during anesthesia with fentanyl-fluanisone (0.0945 mg/kg body wt and 0.3 mg/kg body wt, respectively; Janssen, Copenhagen, Denmark) and midazolam (0.25 mg/kg body wt, Dumex; Alpharma, Copenhagen, Denmark). The implantation of pellets was repeated 90 d after the first surgical procedure. Five months after the oophorectomy/sham operation, the rats underwent a kidney function study. One week before the functional study, the rats were anesthetized with halothane/N2O, because that anesthesia was better tolerated at that stage of the investigation. With semiaseptic surgical techniques, sterile Tygon catheters (Norton Performance Plastics, Akron, OH) were advanced into the abdominal aorta and the inferior vena cava via the femoral vessels. A sterile chronic suprapubic catheter was implanted in the bladder. All catheters were prepared and fixed, with minor modifications, as described previously (19). After instrumentation, the rats were given saline solution (5 ml, administered subcutaneously) and the long-acting analgesic buprenorphine (10 µg/animal, administered subcutaneously, Temgesic; Reckitt & Colman, Hull, UK). The animals were housed individually and, after a recovery period of 3 to 5 d, were accustomed to restriction with daily training sessions in restraining cages. The duration of the daily sessions was gradually increased from 1 to 3 h.

Experimental Design
On the basis of vaginal smears, the sham-operated animals were determined to be in proestrus the day before the kidney function experiments. From all groups, two rats were randomly chosen for time-control experiments the day after the kidney function experiments. Renal function was measured during a control period, followed by a period during which glycine was infused. Time-control animals were treated similarly except that glycine was replaced by vehicle alone. Each experiment included a 15-min bolus period for infusion of renal markers, a 105-min equilibration period, three 20-min baseline urine collection periods, a 60-min glycine equilibration period, and three 20-min test urine collection periods, during which glycine was infused.

Renal Clearance Protocol
The experiments were performed between 9 a.m. and 2 p.m. Each rat was transferred to a restraining cage and was connected to infusion pumps via the venous catheter and to a BP transducer (Baxter Uniflow; Bentley Laboratories Europe BV, Uden, Holland) via the arterial catheter.

Through the pressure transducer, a continuous intra-arterial infusion of 25 to 50 mM glucose solution containing heparin (100 U/ml) was administered at a rate of 5 µl/min, to keep the arterial catheter open. In addition, the animals received, throughout the experiments, an intravenous infusion of 25 to 50 mM glucose solution (bolus, 0.6 ml; sustained infusion, 10 µl/min) containing [14C]tetraethylammonium bromide (TEA) (bolus, 31 kBq; sustained infusion, 0.52 kBq/min; New England Nuclear, Boston, MA), [3H]inulin (bolus, 67 kBq; sustained infusion, 1.1 kBq/min; Amersham International, Rainham, UK), and lithium (bolus, 7.2 µmol; sustained infusion, 0.12 µmol/min), as markers of ERPF, GFR, and proximal tubular fluid output, respectively. Furthermore, the animals received 25 to 50 mM glucose solution at a rate of 30 µl/min to maintain an adequate urine flow, which was necessary for elimination of bladder-emptying errors. Glycine (4 mg/min) was administered with the glucose solution. During glycine infusion, net losses of water and sodium were replaced with a personal computer-controlled servo-system, as previously described (20). The fluid infusion rate was calculated by taking into account the 45 µl/min of fluid continuously administered throughout the study and the variable amount of fluid administered by the NaCl solution pump.

Blood samples (200 µl) were withdrawn from the arterial catheter at 0, 120, 180, 240, and 300 min. Replacement donor blood was administered after each blood sample was withdrawn. The time-control rats underwent the experiment once more but were treated with vehicle instead of glycine after 180 min.

Analyses
Urine volume was determined by gravimetry. Concentrations of sodium and potassium in plasma and urine and of lithium in plasma were determined by flame emission photometry. Lithium concentrations in urine were determined by atomic absorption spectrophotometry. [14C]TEA and [3H]inulin concentrations in plasma and urine were determined by dual-label liquid scintillation counting with a Packard Tri-Carb liquid scintillation analyzer (model 1900CA; Packard Instruments, Greve, Denmark). The sample (15 µl) and 285 µl of water were mixed with 2.5 ml of Ultima Gold scintillation liquid (Packard Instruments). Concentration calculations were performed with automatic efficiency control.

Calculations
Renal clearances (C) and fractional excretions (FE) were calculated with the standard formulas C = U x V/P and FE = C/GFR, where U is the urinary concentration, V is the urine flow rate, and P is the plasma concentration. In previous studies, the renal extraction fraction of TEA was demonstrated to be approximately 90% and the validity of using TEA to estimate ERPF was documented (21,22). At the concentration used in this study, TEA is without effects on efferent renal sympathetic nerve activity in rats (23). Using the clearances of TEA, inulin, and lithium, the following parameters were calculated: ERPF (TEA clearance), GFR (inulin clearance), filtration fraction (100 x inulin clearance/TEA clearance), proximal tubular fluid output (lithium clearance), and renal vascular resistance [(mean arterial pressure - 5) x (1 - hematocrit)/TEA clearance]. In all calculations, it was assumed that the renal venous pressure was 5 mmHg throughout the experiment.

Bioelectric Impedance Measurements
Before the rats were euthanized, body weights were measured and the animals were anesthetized with phenobarbital (50 mg/kg body wt, administered intraperitoneally). Bioelectric impedance was then measured in the frequency range of 4 to 1024 kHz with a multifrequency bioimpedance spectroscopic analyzer (SFB3; UniQuest Ltd., Brisbane, Australia), as described previously (24). In brief, stainless-steel electrodes were inserted 3 to 5 mm subcutaneously. The source electrodes were inserted in the midline between the auricles and at the midpoint between the iliac crests, and the detector electrodes were inserted at the base of the tail and in the midline between the anterior edges of the orbits. Assuming an hydration value of 0.732, the following equation was used to calculate the fat-free mass: fat-free mass = [(131.2981 x L2/Zc) + 37.3184]/0.732, where L is the conductor length (in centimeters) and Zc is the magnitude of impedance (Ward et al., personal communication). The fat mass was calculated as fat mass = body weight - fat-free mass.

Organ Weights
After euthanasia, the wet weights of the uterus, kidneys, heart, gastrocnemius muscle, and liver were recorded for all animals.

Data Presentation and Statistical Analyses
All values are presented as mean ± SEM. Overall statistical analyses were performed with ANOVA between groups or one-way ANOVA within groups. The test periods were compared with the baseline period with the t test for paired data or a nonparametric analysis (Wilcoxon test), when the variance differed significantly between the periods. Differences between groups were tested with the t test or a nonparametric analysis (Mann-Whitney test), when the variance differed significantly between the groups. Differences were considered statistically significant at the 0.05 level.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Plasma Values
The plasma values are presented in Table 1. In the baseline period and the glycine period, there were no differences in the plasma concentrations of sodium, potassium, and lithium between the groups. The hematocrit values were significantly lower in the OOX+E2 and OOX+E2+P groups, compared with the OOX group, whereas there was no change in the sham group. There were no significant differences in mean BP between the groups.


View this table:
[in this window]
[in a new window]

  		Table 1. Plasma values, hematocrit, and mean arterial BP in rats that were oophorectomized at the age of 8 mo and monitored for 5 moa
 
The plasma concentrations of sodium and potassium were not affected by glycine administration in any of the groups. In all of the groups given glycine, there was a significant decrease in the mean plasma lithium concentration. In the time-control group, there was no change in the plasma lithium concentration. Hematocrit and mean arterial pressure values were not affected by glycine.

Renal Hemodynamics and Segmental Tubular Handling of Sodium and Water
In the baseline period, there was no difference between the groups with respect to ERPF, renal vascular resistance, or GFR (Figure 1). In contrast, the OOX+E2, OOX+E2+P, and sham groups demonstrated significantly higher values for proximal tubular fluid output and fractional lithium excretion, compared with the OOX group (Table 2). Also, the clearance and fractional excretion of potassium were higher in the groups treated with sex hormones than in the placebo-treated group.



View larger version (18K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Figure 1. Effective renal plasma flow (ERPF), renal vascular resistance (RVR), and GFR in four groups of rats that were oophorectomized at the age of 8 mo and were monitored for 5 mo, as follows: oophorectomized and given placebo (OOX group), oophorectomized and substituted with 17{beta}-estradiol (OOX+E2 group), oophorectomized and substituted with 17{beta}-estradiol and progesterone (OOX+E2+P group), and sham-operated (sham group). *P < 0.05, OOX group versus any other group. {dagger}P < 0.05, {dagger}{dagger}P < 0.01, {dagger}{dagger}{dagger}P < 0.001, vehicle versus glycine. White bars, baseline values; black bars, values during infusion of glycine.

 

View this table:
[in this window]
[in a new window]

  		Table 2. Renal variables in rats that were oophorectomized at the age of 8 mo and monitored for 5 moa
 
Infusion of glycine led to ERPF increases that were significantly greater in the OOX+E2 and OOX+E2+P groups, compared with the OOX group, in which there was no change (Figure 1). Similarly, glycine led to GFR increases that were significantly greater in the OOX+E2, OOX+E2+P, and sham groups, compared with the OOX group, in which there was no change. Absolute proximal reabsorption (APR) decreased significantly in the OOX and sham groups, suggesting that glycine inhibits APR. In the two hormone-substituted groups, large increases in GFR were accompanied by no changes in APR (-84 and 15 µl/min). This is also an indication of a direct inhibitory effect on proximal reabsorption, because an increase in GFR should cause proximal tubular reabsorption to increase. Assuming that the glycine-induced changes in GFR would lead to proportional increases in APR with unaltered fractional proximal reabsorption, we calculated hypothetical APR values. Those values were compared with the actual measured values to yield an estimate of the effect of glycine on APR in the various groups. As demonstrated in Figure 2, this comparison revealed that glycine led to inhibition of APR in all groups. The inhibition seemed to be similar in all groups, i.e., independent of the preceding hormone treatment. The increases in proximal tubular fluid output, sodium clearance, and potassium clearance were similar to the changes in the OOX group (Table 2). The time-control group demonstrated no alterations in any of the variables except the urine flow rate, which exhibited a small increase (data not shown).



View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Figure 2. Changes in GFR versus measured ({circ} and hypothetical (•) changes in absolute proximal reabsorption (APR) in response to glycine in the four groups under investigation. The hypothetical changes in APR were calculated as {Delta}GFR x fractional proximal reabsorption before glycine.

 
The weights of various organs in the different groups are presented in Table 3. The weights of the uterus and liver were increased and the body weight and fat mass were decreased in the OOX+E2, OOX+E2+P, and sham groups, compared with the OOX group.


View this table:
[in this window]
[in a new window]

  		Table 3. Body weight and weight of various organs in rats that were oophorectomized at the age of 8 mo and monitored for 5 moa
 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
This study examined for the first time the effect of estrogen on the preservation of kidney function in aging female rats. The results indicated that rats that were oophorectomized at the age of 8 mo and were monitored for 5 mo demonstrated normal baseline GFR, compared with sex hormone-supplemented rats or sham-operated rats with intact estrous cycles. However, when the renal functional reserve was examined with maximal stimulation with glycine, interesting significant differences between the groups were observed. Rats deprived of estrogen were unable to increase the GFR, whereas rats treated with estrogen exhibited a preserved renal functional reserve. The sham-operated group, being middle-aged rats and therefore having waning estrous cycles, demonstrated some renal functional reserve, although it was significantly lower than that observed in the substituted rats, which had been given a full substitution dose of sex hormones during the preceding 5 mo. These observations suggest that, although a protective effect of estrogen on GFR could not be demonstrated, protection of the renal functional reserve in female Wistar rats was evident.

ERPF exhibited the same pattern as GFR. There was no difference between the groups in the baseline period, whereas groups receiving or producing estrogen were able to increase ERPF after the administration of glycine, because of a reduction of the renal vascular resistance. The placebo-treated group was the only group that did not respond to glycine with an increase in ERPF. These observations suggest that estrogen preserved the vascular vasodilating reactivity to glycine in oophorectomized rats.

It has long been suggested that estrogen protects women against hypertension and coronary artery disease and that the effect of estrogen is to potentiate endothelium-dependent vasodilation, rather than being vasodilating itself (25). For example, it was demonstrated that long-term estrogen replacement therapy increased vasodilation in response to ischemia in the forearm resistance arteries in postmenopausal women (26), and it was demonstrated that ovariectomy of rats caused a loss of acetylcholine-mediated dilation within weeks (27). However, to fully appreciate the interaction between estrogen and glycine observed in this study, it is necessary to further explore the mechanisms underlying the vascular effects of estrogen and glycine.

Effects of Estrogen
Estrogen increases bioactive nitric oxide (NO) contents in vascular endothelial cells. This could be the result of stimulated NO production with increased NO synthase expression and activity (28), or it could be attributable to reduced degradation of NO because of inhibition of superoxide anion production (29).

In addition, estrogen has been demonstrated to interfere with the renin-angiotensin system. Estrogen inhibits circulating renin and angiotensin-converting enzyme, decreases circulating angiotensin II (AngII) levels, and downregulates AngII type 1 receptor expression in vascular smooth muscle cells, adrenal cortex, and hypothalamus (30). Estrogen deficiency as a result of menopause or ovariectomy has the opposite effects on the renin-angiotensin system (30). Furthermore, the vasoconstrictor response to AngII is attenuated by estrogen, whereas estrogen deficiency enhances the vasoconstrictor response to AngII by upregulating AT1 receptors (30). These data suggest that NO and AngII may interact physiologically to maintain vascular endothelial function, and an imbalance of these interactions may play an important role in endothelial dysfunction in hypertension and cardiovascular disease (30). Estrogen changes the balance between NO and AngII, leading to a higher NO/AngII ratio that favors vasodilation.

Furthermore, estrogen may produce its vasodilating effect by interfering with prostaglandins. For example, estrogen stimulates prostacyclin production in human vascular endothelial cells (31), and urinary excretion of prostacyclin increases in postmenopausal women receiving hormone therapy (32). In addition, the effect of estrogen may be related to the release of or sensitivity to endothelium-derived contracting factors such as endothelin-1 (33,34).

Effects of Glycine on GFR
Recent experimental studies demonstrated that the vasodilatory response to glycine depends on the presence of a proper balance between NO and AngII (35), and the renal functional reserve has been proposed as an index of the intrarenal balance between NO and AngII (36,37). Under normal conditions, glycine induces a decrease in renal vascular resistance and a consequent increase in GFR. It has been demonstrated that the response to glycine is inhibited during blockade of the NO system and pretreatment with an AngII inhibitor normalizes the response to glycine. It has also been demonstrated that increases in AngII levels diminish the vasodilatory response. In fact, the absence of a renal functional reserve was observed in experimental models of renal damage, such as renovascular hypertension (38), diabetes mellitus (39), and glomerulonephritis (40). In all of those conditions, angiotensin-converting enzyme inhibitors restored a normal renal functional reserve. Additional studies with human subjects confirmed a role of AngII in the reduction of the renal functional reserve. Among hypertensive patients on a low-salt diet, the consequent activation of the renin-angiotensin system blunted the hemodynamic response to amino acids and the response was restored to normal with angiotensin-converting enzyme inhibitors (41). In other pathophysiologic conditions among human subjects, angiotensin-converting enzyme inhibitors restored the hemodynamic response to amino acids (42,43). Therefore, in different conditions with a prevalence of AngII over NO as a common feature, the renal functional reserve is blunted or absent. This is likely to be caused by overwhelming actions of vasoconstrictor stimuli that offset the normal vasodilatory response to amino acids.

Therefore, the decreased vasodilatory response to glycine in the OOX group in this study could be attributable to an abnormal intrarenal balance between NO and AngII. However, an effect of estrogen on the production of prostaglandins or endothelin-1 cannot be excluded. Estrogen does interfere with both hormone systems, as mentioned above.

Effects of Glycine on Proximal Reabsorption
This study demonstrated fractional lithium excretion from the proximal tubules that was similar to values normally observed under control conditions in our laboratory (44). Only one group demonstrated an abnormal fractional lithium excretion value, namely, the group that neither produced nor received estrogen. Fractional lithium excretion was almost halved in that group, compared with the other groups. It is known that fractional lithium excretion is decreased in conditions involving extracellular volume depletion, such as during treatment with thiazides and in some clinical conditions associated with cardiovascular disease (45). It has also been demonstrated that fractional lithium excretion increases during volume expansion and that NO plays an important role in modulating this response (45). Taken together, these studies suggest that fractional lithium excretion is decreased in conditions with a low renal NO/AngII ratio and is increased in conditions with a high NO/AngII ratio. It may therefore be suggested that fractional lithium excretion is decreased in the OOX group because a lack of estrogen in this group leads to a decrease in the renal NO/AngII ratio, as discussed above.

The administration of glycine led to inhibition of proximal sodium reabsorption in all groups. It has been suggested that inhibition of APR leads to loss of the renal functional reserve because of increased sodium delivery to the macula densa, resulting in activation of the tubuloglomerular feedback mechanism (35). The results of our study did not support this hypothesis. We observed the same increase in proximal tubular fluid output in all groups and should, according to the hypothesis, expect the same reduction in the renal functional reserve in all groups. In fact, only one group, the OOX group, failed to increase GFR; all of the other groups demonstrated normal renal functional reserve. Therefore, we suggest that in our study the glomerular response to glycine was dissociated from the tubular response, as also observed in some other studies (38,39,46,47). The lack of renal functional reserve observed in the OOX group may be attributable to a decreased NO/AngII ratio at the local level, as suggested above.

In conclusion, oophorectomy at the age of 8 mo did not, within a period of 5 mo, produce a decrease in baseline GFR in female rats. However, oophorectomy led to severe decreases in the renal functional reserve and fractional proximal tubular fluid output. Both effects were prevented with the administration of estrogen. The effects of oophorectomy might be attributable to a decrease in the intrarenal NO/AngII ratio.


   Acknowledgments
 
This study was supported by grants from the Danish Medical Research Council (Grant 9700592) and the Novo-Nordisk Foundation. We thank Jette Birk and Kirsten Nyborg for excellent technical assistance.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12: 285–290, 1988[Medline]
  2. Tierney WM, McDonald CJ, Luft FC: Renal disease in hypertensive adults: Effect of race and type II diabetes mellitus. Am J Kidney Dis 13: 485–493, 1989[Medline]
  3. Lopes AA, Port FK, James SA, Agodoa L: The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3: 1961–1971, 1993[Abstract]
  4. Hunt LP, Short CD, Mallick NP: Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 34: 382–388, 1988[Medline]
  5. Hannedouche T, Chauveau P, Kalou F, Albouze G, Lacour B, Jungers P: Factors affecting progression in advanced chronic renal failure. Clin Nephrol 39: 312–320, 1993[Medline]
  6. Rekola S, Bergstrand A, Bucht H: Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int 40: 1050–1054, 1991[Medline]
  7. Lombet JR, Adler SG, Anderson PS, Nast CC, Olsen DR, Glassock RJ: Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114: 66–74, 1989[Medline]
  8. Hajdu A, Rona G: The protective effect of estrogens against spontaneous pancreatic islet and renal changes in aging male rats. Experientia 27: 956–957, 1971[CrossRef][Medline]
  9. Kwan G, Neugarten J, Sherman M, Ding Q, Fotadar U, Lei J, Silbiger S: Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 50: 1173–1179, 1996[Medline]
  10. Neugarten J, Ghossein C, Silbiger S: Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein. J Lab Clin Med 126: 385–391, 1995[Medline]
  11. Beldekas JC, Gerstenfeld L, Sonenshein GE, Franzblau C: Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J Biol Chem 257: 12252–12256, 1982[Abstract/Free Full Text]
  12. Beldekas JC, Smith B, Gerstenfeld LC, Sonenshein GE, Franzblau C: Effects of 17{beta}-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry 20: 2162–2167, 1981[CrossRef][Medline]
  13. Rajabi MR, Solomon S, Poole AR: Activation of protein kinase C stimulates collagenase production by cultured cells of the cervix of the pregnant guinea pig. Am J Obstet Gynecol 167: 194–200, 1992[Medline]
  14. Baylis C: Age-dependent glomerular damage in the rat: Dissociation between glomerular injury and both glomerular hypertension and hypertrophy: Male gender as a primary risk factor. J Clin Invest 94: 1823–1829, 1994
  15. Sakemi T, Toyoshima H, Morito F: Testosterone eliminates the attenuating effect of castration on the progressive glomerular injury in hypercholesterolemic male Imai rats. Nephron 67: 469–476, 1994[Medline]
  16. Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ: Estrogen-related abnormalities in glomerulosclerosis-prone mice: Reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 160: 1877–1885, 2002[Abstract/Free Full Text]
  17. Elema JD, Arends A: Focal and segmental glomerular hyalinosis and sclerosis in the rat. Lab Invest 33: 554–561, 1975[Medline]
  18. Shalmi M, Thomsen K: Alterations of lithium clearance in rats by different modes of lithium administration. Ren Physiol Biochem 12: 273–280, 1989[Medline]
  19. Petersen JS, Shalmi M, Lam HR, Christensen S: Renal response to furosemide in conscious rats: Effects of acute instrumentation and peripheral sympathectomy. J Pharmacol Exp Ther 258: 1–7, 1991[Abstract/Free Full Text]
  20. Spannow J, Thomsen K, Petersen JS, Haugan K, Christensen S: Influence of renal nerves and sodium balance on the acute antidiuretic effect of bendroflumethiazide in rats with diabetes insipidus. J Pharmacol Exp Ther 282: 1155–1162, 1997[Abstract/Free Full Text]
  21. Petersen JS, Christensen S: Superiority of tetraethylammonium to p-aminohippurate as a marker for renal plasma flow during furosemide diuresis. Ren Physiol 10: 102–109, 1987[Medline]
  22. Rasmussen SN, Shalmi M, Hansen M, Christensen S: Tetraethylammonium and p-aminohippurate as clearance markers for renal plasma flow in the rat during saline and glucose infusion. Ren Physiol Biochem 13: 314–323, 1990[Medline]
  23. Petersen JS, DiBona GF: Ganglionic blockade with tetraethylammonium in conscious rats. Hypertension 19: 814–817, 1992[Abstract/Free Full Text]
  24. Rutter K, Hennoste L, Ward LC, Cornish BH, Thomas BJ: Bioelectrical impedance analysis for the estimation of body composition in rats. Lab Anim 32: 65–71, 1998[Abstract/Free Full Text]
  25. Thompson J, Khalil RA: Gender differences in the regulation of vascular tone. Clin Exp Pharmacol Physiol 30: 1–15, 2003[CrossRef][Medline]
  26. Higashi Y, Sanada M, Sasaki S, Nakagawa K, Goto C, Matsuura H, Ohama K, Chayama K, Oshima T: Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women. Hypertension 37: 651–657, 2001[Abstract/Free Full Text]
  27. Moien-Afshari F, Kenyon E, Choy JC, Battistini B, McManus BM, Laher I: Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats. Maturitas 45: 213–223, 2003[CrossRef][Medline]
  28. Knot HJ, Lounsbury KM, Brayden JE, Nelson MT: Gender differences in coronary artery diameter reflect changes in both endothelial Ca2+ and ecNOS activity. Am J Physiol 276: H961–H969, 1999
  29. Lam K-K, Ho ST, Yen MH: Tetrahydrobiopterin improves vascular endothelial function in ovariectomized rats. J Biomed Sci 9: 119–125, 2002[CrossRef][Medline]
  30. Zhuo JL: Angiotensin II type 1 receptors and oestrogen status: Interaction or dissociation? J Hypertens 20: 1267–1269, 2002[CrossRef][Medline]
  31. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O: 17{beta}-Estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 80: 1832–1836, 1995[Abstract]
  32. Mueck AO, Seeger H, Lippert C, Wallwiener D: Urinary excretion of vasoactive markers following estrogen replacement therapy in postmenopausal women. Int J Clin Pharmacol Ther 38: 381–386, 2000[Medline]
  33. Takaoka M, Yuba M, Fujii T, Ohkita M, Matsumura Y: Oestrogen protects against ischaemic acute renal failure in rats by suppressing renal endothelin-1 overproduction. Clin Sci 103 [Suppl 48]: 434S–437S, 2002
  34. Tostes RC, David FL, Carvalho MH, Nigro D, Scivoletto R, Fortes ZB: Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats. J Cardiovasc Pharmacol 36 [Suppl 1]: S99–S101, 2000[Medline]
  35. Gabbai FB, De Nicola L, Garcia GE, Blantz RC: Role of angiotensin in the regulation of renal response to proteins. Semin Nephrol 15: 396–404, 1995[Medline]
  36. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angiotensin II: Glomerular and tubular interaction in the rat. J Clin Invest 89: 1248–1256, 1992
  37. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92: 1859–1865, 1993
  38. De Nicola L, Keiser JA, Blantz RC, Gabbai FB: Angiotensin II and renal functional reserve in rats with Goldblatt hypertension. Hypertension 19: 790–794, 1992[Abstract/Free Full Text]
  39. De Nicola L, Blantz RC, Gabbai FB: Renal functional reserve in the early stage of experimental diabetes. Diabetes 41: 267–273, 1992[Abstract]
  40. De Nicola L, Peterson OW, Obagi S, Kaiser JA, Wilson CB, Gabbai FB: Renal functional reserve in experimental chronic glomerulonephritis. Nephrol Dial Transplant 9: 1383–1389, 1994[Abstract/Free Full Text]
  41. Juncos L, Cornejo JC, Pamies-Andreu E, Romero JC: Renal response to amino acid infusion in essential hypertension. Hypertension 23: I225–I230, 1994
  42. Slomowitz LA, Hirschberg R, Kopple JD: Captopril augments the renal response to an amino acid infusion in diabetic adults. Am J Physiol 255: F755–F762, 1988
  43. Bochicchio T, Sandoval G, Ron O, Perez-Grovas H, Bordes J, Herrera-Acosta J: Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives. Kidney Int 38: 873–879, 1990[Medline]
  44. Thomsen K, Nielsen CB, Flyvbjerg A: Effects of glycine on glomerular filtration rate and segmental tubular handling of sodium in conscious rats. Clin Exp Pharmacol Physiol 29: 449–454, 2002[CrossRef][Medline]
  45. Thomsen K, Shirley DG: Importance of proximal tubular fluid output in regulating long-term urinary sodium excretion in health and disease. Nephron 90: 121–132, 2002[CrossRef][Medline]
  46. Magri P, Rao MA, Cangianiello S, Bellizzi V, Russo R, Mele AF, Andreucci M, Memoli B, De Nicola L, Volpe M: Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 98: 2849–2854, 1998[Abstract/Free Full Text]
  47. Slomowitz LA, Peterson OW, Thomson SC: Converting enzyme inhibition and the glomerular hemodynamic response to glycine in diabetic rats. J Am Soc Nephrol 10: 1447–1454, 1999[Abstract/Free Full Text]
Received for publication March 3, 2003. Accepted for publication August 27, 2003.




This article has been cited by other articles:


Home page
 HypertensionHome page
L. L. Yanes, J. C. Sartori-Valinotti, and J. F. Reckelhoff
Sex Steroids and Renal Disease: Lessons From Animal Studies
Hypertension, April 1, 2008; 51(4): 976 - 981.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Loria, V. Reverte, F. Salazar, F. Saez, M. T. Llinas, and F. J. Salazar
Changes in renal hemodynamics and excretory function induced by a reduction of ANG II effects during renal development
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R695 - R700.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Karl, M. Berho, J. Pignac-Kobinger, G. E. Striker, and S. J. Elliot
Differential Effects of Continuous and Intermittent 17{beta}-Estradiol Replacement and Tamoxifen Therapy on the Prevention of Glomerulosclerosis: Modulation of the Mesangial Cell Phenotype in Vivo
Am. J. Pathol., August 1, 2006; 169(2): 351 - 361.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nielsen, C. B.
Right arrow Articles by Thomsen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, C. B.
Right arrow Articles by Thomsen, K.

HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP